Finally, a role of KMT2C as a 7q haplo‐insufficient tumor suppressor gene has been proposed in acute myeloid leukemia in mice, by impairing the differentiation of HSPC and cooperating with other established AML lesions [37]. This evidence concerns the gene KMT2C and acute myeloid leukemia.